Skip to content

Investigating the Effects of Krill Oil and Krill Protein on Post-exercise Muscle Protein Metabolism

Investigating the Effects of Krill Oil and Krill Protein on Post-exercise Muscle Protein Metabolism: a Randomised Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05774444
Acronym
KIPLING
Enrollment
48
Registered
2023-03-17
Start date
2023-05-01
Completion date
2025-05-25
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophy

Keywords

Omega-3, Krill oil, Protein, Exercise

Brief summary

The aim of the current study is to find out if krill oil can increase muscle building processes in response to resistance (weightlifting) type exercise. Others aim are to determine the effects of krill protein, and the interaction of krill oil and protein, on muscle building processes in response to resistance (weightlifting) type exercise.

Interventions

DIETARY_SUPPLEMENTKrill oil

Krill oil will be supplemented to see if they can gain strength and/or muscle mass following supplementation.

DIETARY_SUPPLEMENTKrill protein

Krill protein will be given to the participant following a resistance exercise bout.

DIETARY_SUPPLEMENTVegetable oil

This will be the control against the Krill oil

DIETARY_SUPPLEMENTCarbohydrate

This will be the control for the Krill protein

Sponsors

Aker BioMarine
CollaboratorUNKNOWN
University of Glasgow
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

All supplements with be colour and flavour matched

Intervention model description

Parallel 2x2 factorial design

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Be 60 years old or older * Have a BMI of less than 35kg/m2 * Be participating in structured exercise for less than 2h per week

Exclusion criteria

* Diabetes * Severe cardiovascular disease * Seizure disorders, * Uncontrolled hypertension (\>150/90mmHg at baseline measurement) * Cancer or cancer that has been in remission \<5 years * Ambulatory impairments which would limit ability to perform assessments of muscle function * Dementia * Taking medication known to affect muscle (e.g., steroids) * Have an implanted electronic device (e.g., pacemaker/defibrillator/insulin pump), * Anticoagulant therapy * Allergies to seafood * Regular consumption of more than 1 portion of oily fish per week.

Design outcomes

Primary

MeasureTime frameDescription
Post-exercise muscle protein synthesis3-7 hoursMuscle protein synthesis measured 3-7h after a single bout of resistance exercise

Secondary

MeasureTime frameDescription
Change in Muscle thicknessChange from baseline to 8 weeksVastus lateralis muscle thickness measured by ultrasound
Change in grip strengthChange from baseline to 8 weeksGrip strength measured with a Jamar dynamometer
Change in fat massChange from baseline to 8 weeksWhole body fat mass measured by BIA
Change in muscle strengthChange from baseline to 8 weeksKnee extensor muscle strength measured isometrically
Change in lean massChange from baseline to 8 weeksWhole body lean mass measured by BIA
Change in balanceChange from baseline to 8 weeksAbility to stand for 10 seconds in full tandem, semi-tandem and feet together
Change in gait speedChange from baseline to 8 weeksTime taken to walk 4 metres at a normal walking pace
Basal muscle protein synthesis0-3 hoursMuscle protein synthesis measured from 0-3h after an overnight fast
Change in Erythrocyte fatty acid profileChange from baseline to 8 weeksErythrocyte fatty acid profile
Change in Chair rise timeChange from baseline to 8 weeksTime taken to get up and down from a chair 5 times

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026